Jia Fan

Summary

Publications

  1. ncbi request reprint Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma
    Kang Song
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Hepatobiliary Pancreat Dis Int 11:177-84. 2012
  2. ncbi request reprint Complete resection of the caudate lobe of the liver with tumor: technique and experience
    J Fan
    Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical University, 136 Yi Xue Yuan Road, Shanghai, 200032 P R China
    Hepatogastroenterology 48:808-11. 2001
  3. ncbi request reprint Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
    Jia Fan
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yixueyuan Road, Shanghai 200032, China
    World J Gastroenterol 11:1215-9. 2005
  4. doi request reprint Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
    Jia Fan
    Liver Cancer Institute, Shanghai Medical School, Zhong Shan Hospital, Fudan University, 200032 Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:1403-12. 2009
  5. ncbi request reprint Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments
    Jia Fan
    Liver Cancer Institute, Zhongshan Hospital, Fudan University Shanghai Medical School, 136 Yi Xue Yuan Road, Shanghai 200032, China
    Hepatobiliary Pancreat Dis Int 2:513-9. 2003
  6. doi request reprint Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma
    Jian Zhou
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, People s Republic of China
    J Clin Oncol 29:4781-8. 2011
  7. pmc Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma
    Ranjan Prasad Devbhandari
    Liver Cancer Institute, Shanghai Medical School, Fudan University, Zhongshan Hospital, Shanghai, People s Republic of China
    PLoS ONE 6:e24901. 2011
  8. ncbi request reprint [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft]
    Yong Sheng Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 85:3205-9. 2005
  9. doi request reprint Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
    Kai Zhu
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Shanghai, China
    Clin Cancer Res 17:7294-302. 2011
  10. ncbi request reprint [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]
    Jian Zhou
    Liver Cancer Institute, Zhongshan Hospital, Fudam University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 86:3005-8. 2006

Collaborators

Detail Information

Publications129 found, 100 shown here

  1. ncbi request reprint Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma
    Kang Song
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Hepatobiliary Pancreat Dis Int 11:177-84. 2012
    ..However, the prognostic value of Spry2 in cancer patients remains unknown. This study is aimed to investigate the clinical relevance and prognostic significance of Spry2 expression in patients with hepatocellular carcinoma (HCC)...
  2. ncbi request reprint Complete resection of the caudate lobe of the liver with tumor: technique and experience
    J Fan
    Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical University, 136 Yi Xue Yuan Road, Shanghai, 200032 P R China
    Hepatogastroenterology 48:808-11. 2001
    ..To study the technique and curative effects of complete resection of the caudate lobe of the liver with tumors...
  3. ncbi request reprint Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
    Jia Fan
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yixueyuan Road, Shanghai 200032, China
    World J Gastroenterol 11:1215-9. 2005
    ..To evaluate the efficacy of different treatment strategies for hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) and investigate factors influencing prognosis...
  4. doi request reprint Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
    Jia Fan
    Liver Cancer Institute, Shanghai Medical School, Zhong Shan Hospital, Fudan University, 200032 Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:1403-12. 2009
    ..To evaluate current selection criteria for patients undergoing liver transplantation (LT) in response to hepatocellular carcinoma (HCC), and to analyze the prognostic factors for successful transplantation...
  5. ncbi request reprint Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments
    Jia Fan
    Liver Cancer Institute, Zhongshan Hospital, Fudan University Shanghai Medical School, 136 Yi Xue Yuan Road, Shanghai 200032, China
    Hepatobiliary Pancreat Dis Int 2:513-9. 2003
    ..To compare the effects of different treatments for hepatocellular carcinoma (HCC) with tumor thrombosis in the portal vein (TTPV) and evaluate the factors influencing the prognosis...
  6. doi request reprint Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma
    Jian Zhou
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, People s Republic of China
    J Clin Oncol 29:4781-8. 2011
    ..We aimed to identify plasma microRNAs for diagnosing hepatitis B virus (HBV) -related HCC...
  7. pmc Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma
    Ranjan Prasad Devbhandari
    Liver Cancer Institute, Shanghai Medical School, Fudan University, Zhongshan Hospital, Shanghai, People s Republic of China
    PLoS ONE 6:e24901. 2011
    ..Together, our data show that CD151 acts as an important player in the progression of HCC in an integrin β1-dependent manner...
  8. ncbi request reprint [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft]
    Yong Sheng Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 85:3205-9. 2005
    ..To further study the impact of interferon-alpha (IFN-alpha) on thymidine phosphorylase (TP) expression and angiogenesis...
  9. doi request reprint Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
    Kai Zhu
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Shanghai, China
    Clin Cancer Res 17:7294-302. 2011
    ..To investigate the expression of metadherin (MTDH) for its prognostic value in hepatocellular carcinoma (HCC) and its role in promoting HCC metastasis...
  10. ncbi request reprint [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]
    Jian Zhou
    Liver Cancer Institute, Zhongshan Hospital, Fudam University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 86:3005-8. 2006
    ..To investigate the surgical outcome of the hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) after surgery and the time-dependency of the factors influencing survival...
  11. doi request reprint Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma
    Dou sheng Bai
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, PR China
    Hepatology 49:460-70. 2009
    ..Conclusion: Our study revealed that Capn4 overexpression underlies invasion and metastasis after LT for HCC and might be a candidate biomarker for future diagnosis and a target for therapy...
  12. ncbi request reprint [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]
    Zheng Wang
    Liver Cancer Institute, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 86:1666-70. 2006
    ..To investigate the effects of rapamycin (RPM) in inhibiting the growth and metastasis of hepatocellular carcinoma (HCC)...
  13. doi request reprint Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma
    Zheng Wang
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:715-22. 2009
    ..Sirolimus, a potent immunosuppressant, has been reported to be an effective inhibitor in a variety of tumors. The present study is designed to explore whether sirolimus could block the growth and metastatic progression of HCC...
  14. doi request reprint CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma
    Guo Ming Shi
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai, People s Republic of China
    Hepatology 52:183-96. 2010
    ..Multivariate Cox proportional hazards analysis showed that the concomitant overexpression of CD151, MMP9, and MVD was an independent marker for predicting poor prognosis of HCC...
  15. doi request reprint An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels
    Zheng Wang
    Fudan University, Liver Cancer Institute and Zhongshan Hospital, Shanghai, P R China
    Expert Opin Investig Drugs 20:1039-45. 2011
    ..Conclusions: Sorafenib inhibits tumor growth and prevents metastatic recurrence after resection of hepatocellular carcinoma in nude mice. The effect of sorafenib does not exclusively depend on high levels of pERK in tumors...
  16. pmc Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma
    Rui Liao
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    J Exp Clin Cancer Res 32:22. 2013
    ..Therefore, we identified the phenotypic and genomic characteristics of peritumoral HSCs to explore the valuable information on the prognosis and therapeutic targets of HBV related HCC...
  17. doi request reprint High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection
    Jie Hu
    Key Laboratory for Carcinogenesis and Cancer Invasion, the Chinese Ministry of Education, Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, 200032 Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:1359-67. 2009
    ..To evaluate the prognosis value of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) in alpha-fetoprotein (AFP)-negative hepatocellular carcinoma (HCC) patients after curative resection...
  18. doi request reprint Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma
    Zheng Wang
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, PR China
    Clin Cancer Res 14:5124-30. 2008
    ..This study was to investigate the effect of rapamycin, alone and in combination with sorafenib, on HCC in vivo...
  19. doi request reprint αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
    Xiao Yong Huang
    Liver Cancer Institute, Zhongshan Hospital, Fudan University Key Laboratory of Carcinogenesis and Cancer Invasion Fudan University, Ministry of Education, Shanghai, PR China
    Hepatology 57:2235-47. 2013
    ..This study reveals αB-Crystallin as a potential therapeutic target for HCC and a biomarker for predicting sorafenib treatment response. (HEPATOLOGY 2013)...
  20. doi request reprint Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection
    Min Jie Ju
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School of Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, Chinese Ministry of Education, Shanghai, Peoples Republic of China
    Am J Clin Pathol 131:498-510. 2009
    ..It is important to note that the density of peritumoral activated HSCs, in combination with seprase and osteonectin mRNA or density of Tregs and MPhi, might predict prognoses more effectively...
  21. ncbi request reprint Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Cancer J 12:113-22. 2006
    ..We undertook this study to determine if radiotherapy is appropriate for patients with unresectable or lymph node metastatic intrahepatic cholangiocarcinoma...
  22. doi request reprint Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma
    Zhen Bin Ding
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    Cancer 115:4753-65. 2009
    ..The study was designed to investigate the role of LI-cadherin in tumor invasion and prognosis of human hepatitis B virus (HBV)-positive hepatocellular carcinoma (HCC)...
  23. doi request reprint The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
    Ning Zhang
    Liver Cancer Institute of Fudan University, 200032 Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:1447-53. 2009
    ..The chemical structure of YSV is l-tyrosine-l-serine-l-valine, molecular structure is C(17)H(25)N(3)O(6), and molecular weight is 367.40 Da) on human hepatocarcinoma SMMC-7721 transplanted tumors in nude mice...
  24. doi request reprint High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
    Xin Rong Yang
    Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, 136 Yi Xue Yuan Road, Shanghai, PR China
    Gut 59:953-62. 2010
    ..To investigate the prognostic values of putative hepatic stem/progenitor cell (HSC/HPC) biomarkers in patients with hepatocellular carcinoma (HCC)...
  25. doi request reprint Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume
    Ai Hong Bi
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Int J Radiat Oncol Biol Phys 78:1427-36. 2010
    ..To quantify microscopic invasion of intrahepatic cholangiocarcinoma (IHC) into nontumor tissue and define the gross tumor volume (GTV)-to-clinical target volume (CTV) expansion necessary for radiotherapy...
  26. doi request reprint Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth
    Zheng Wang
    Fudan University, Liver Cancer Institute and Zhongshan Hospital, 136 Yi Xue Yuan Road, 200032 Shanghai, PR China
    Expert Opin Investig Drugs 18:1595-604. 2009
    ..To date, no detailed data are available about the effects of oxaliplatin on hepatocellular carcinoma (HCC) cells. Herein, the anti-proliferation effects of oxaliplatin on HCCLM3 and Hep3B cells in vitro and in vivo are studied...
  27. doi request reprint Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
    Ying Hong Shi
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    Autophagy 7:1159-72. 2011
    ..The combination of autophagy modulation and molecular targeted therapy is a promising therapeutic strategy in treatment of HCC...
  28. doi request reprint Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection
    Ming Yan Cai
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Shanghai 200032, People s Republic of China
    Clin Cancer Res 15:4686-93. 2009
    ..Human leukocyte antigen-G (HLA-G) is a tumor-associated immunosuppressive molecule involved in tumor escape mechanisms. The aim of this study is to elucidate its prognostic significance in hepatocellular carcinoma (HCC)...
  29. ncbi request reprint Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice
    Yong Sheng Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032 Shanghai, P R China
    J Cancer Res Clin Oncol 130:546-50. 2004
    ..To investigate the antitumor effect of interferon-alpha 2a (IFN-alpha2a) combined with capecitabine on hepatocellular carcinoma (HCC) in nude mice in relation to thymidine phosphorylase (TP) expression...
  30. pmc α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy
    Yuan Fei Peng
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, PR China
    PLoS ONE 8:e53072. 2013
    ..The purpose of this study is to develop an HCC tissue-specific RNAi system and investigate its possibility for HCC treatment...
  31. doi request reprint Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma
    Fang Ming Gu
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai, People s Republic of China
    Ann Surg Oncol 19:2506-14. 2012
    ..This study was designed to assess the clinical significance of tumor-infiltrating inflammatory cells in patients with intrahepatic cholangiocarcinoma (ICC)...
  32. doi request reprint Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis
    Xin Yin
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, Chinese Ministry of Education, Shanghai, People s Republic of China
    Ann Surg Oncol 19:2869-76. 2012
    ..The aim of this study was to clarify the clinical features, treatment modalities, and prognosis of cHCC-CC...
  33. pmc The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma
    Jing Ai
    Division of Anti tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, Shanghai, People s Republic of China
    J Natl Cancer Inst 103:1696-712. 2011
    ..Abnormal expression of pIgR in cancer was also observed, but its clinical relevance remains uncertain...
  34. doi request reprint Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma
    Ying Liang
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, People s Republic of China
    Int J Cancer 130:1745-54. 2012
    ..In summary, ARNT is an important regulator of HCC growth and metastasis and could be a promising prognostic candidate in HCC patients...
  35. ncbi request reprint [Interferon alpha enhances the sensitivity of SMMC-7721 hepatocellular carcinoma cells to 5'-deoxy-5-fluorouridine related to up-regulation of thymidine phosphorylase]
    Yong Sheng Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 87:2098-100. 2007
    ....
  36. doi request reprint Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials
    Guo Ming Shi
    Key Laboratory for Carcinogenesis and Cancer Invasion, Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, the Chinese Ministry of Education, 136 Yi Xue Yuan Road, Shanghai, 200032, People s Republic of China
    J Cancer Res Clin Oncol 134:1155-63. 2008
    ..To identify the side population (SP) cells from four hepatocellular carcinoma (HCC) cell lines with stepwise metastatic potentials...
  37. doi request reprint Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection
    Yi Wei Li
    Liver Cancer Institute, Zhong Shan Hospital and Institutes of Biomedical Sciences, Shanghai Medical School, Fudan University, 136 Yi Xue Yuan Road, 200032, Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 135:439-49. 2009
    ..To evaluate the prognostic value of tumor-associated macrophages (TAM), individually or synergistically with CD45RO + memory T cells (T(M)), in hepatocellular carcinoma (HCC) patients following resection...
  38. doi request reprint Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma
    Xin Da Zhou
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Rd, Shanghai, China
    J Cancer Res Clin Oncol 135:1073-80. 2009
    ..To clarify clinicopathologic differences between patients with intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC), and identify potential factors influencing survival after hepatectomy for ICC...
  39. ncbi request reprint Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration
    Jian Zhou
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, 200032, People s Republic of China
    J Cancer Res Clin Oncol 131:547-51. 2005
    ..To investigate the effects on sensitivity to fluoropyrimidine and endothelial cell (EC) migration by transfection with thymidine phosphorylase (TP) cDNA to a hepatocellular carcinoma (HCC) cell line SMMC-7721...
  40. pmc Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma
    Yang Xu
    Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Key Laboratory for Carcinogenesis and Cancer Invasion, Shanghai, PR China
    Clin Cancer Res 18:1291-302. 2012
    ....
  41. ncbi request reprint Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study
    Zheng gang Ren
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    World J Gastroenterol 10:2791-4. 2004
    ..To evaluate the effect of postoperative adjuvant transcatheter arterial chemoembolization (TACE) on the prognosis of hepatocellular carcinoma (HCC) patients with or without risk factors for the residual tumor...
  42. doi request reprint CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery
    Xin Rong Yang
    Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, Chinese Ministry of Education, Shanghai, People s Republic of China
    Clin Cancer Res 15:5518-27. 2009
    ..To investigate the role of CD24 in tumor invasion and prognostic significance in hepatocellular carcinoma (HCC)...
  43. ncbi request reprint [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]
    Yi Feng He
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 86:1232-5. 2006
    ..To analyze the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma (HCC) and sum up the relevant clinical experience in diagnosis and treatment of HCC...
  44. ncbi request reprint Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma
    Zhao You Tang
    Liver Cancer Institute of Fudan University, 136 Yi Xue Yuan Road, Zhongshan Hospital, Shanghai 200032, China
    Hepatobiliary Pancreat Dis Int 3:495-8. 2004
    ..This study was designed to assess the role of downstaging followed by resection (downstaging-resection) in the improvement of prognosis of unresectable HCC...
  45. ncbi request reprint Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience
    Jian Zhou
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    World J Gastroenterol 12:3114-8. 2006
    ..To report a retrospective analysis of preliminary results of 36 patients who received sirolimus (SRL, Rapamune, rapamycin) in a consecutive cohort of 248 liver allograft recipients...
  46. doi request reprint Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
    Yun Fan Sun
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, PR China
    Hepatology 57:1458-68. 2013
    ..5% versus 87.50%, P < 0.001). EpCAM+ CTCs displayed cancer stem cell biomarkers (CD133 and ABCG2), epithelial-mesenchymal transition, Wnt pathway activation, high tumorigenic potential, and low apoptotic propensity...
  47. doi request reprint High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery
    Ruo Yu Shi
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    Cancer 119:993-1003. 2013
    ..This study sought to investigate the prognostic value of DKK1 in intrahepatic cholangiocarcinoma (ICC) and its role in promoting ICC metastasis...
  48. pmc Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection
    Xiao Yong Huang
    Liver Cancer Institute, Fudan University, Zhongshan Hospital, Shanghai, People s Republic of China
    PLoS ONE 7:e32775. 2012
    ..The aim of this study was to elucidate the expression and mechanism of LRP1 in hepatocellular carcinoma (HCC)...
  49. doi request reprint Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection
    Han Wu
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    J Gastroenterol Hepatol 27:1312-9. 2012
    ..The high expression of the galectin-1 predicts poor patient outcome in several tumors. The aim of this study was to investigate its prognostic value in patients with hepatocellular carcinoma (HCC) after resection...
  50. doi request reprint Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma
    Zuo Lin Xiang
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Clin Cancer Res 17:5463-72. 2011
    ..Differential gene expression profiling is useful for investigating genes associated with lymph node metastasis (LNM). We screened genes to identify potential biomarkers for LNM in HCC...
  51. pmc Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation
    Jie Hu
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, the Chinese Ministry of Education, Shanghai Key Laboratory for Organ Transplantation, Shanghai, People s Republic of China
    PLoS ONE 6:e26003. 2011
    ..Genetic variations play an important role in tumor development and metastasis...
  52. pmc Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation
    Jian He
    Department of Radiation Oncology, Fudan University, Shanghai, China
    BMC Cancer 11:492. 2011
    ..Little is known about the clinical features and prognostic factors of bone metastases of hepatocellular carcinoma (HCC) following liver transplantation (LT)...
  53. pmc Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
    Chen Xin Dai
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai, PR China
    BMC Cancer 9:418. 2009
    ..We investigated the prognostic value of hypoxia-inducible factor-1 alpha (HIF-1alpha) in hepatocellular carcinoma (HCC), and its correlations with inflammation, angiogenesis and MYC oncogene...
  54. ncbi request reprint Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial
    Hui Chuan Sun
    Liver Cancer Institute and Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032, Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 132:458-65. 2006
    ..This study evaluated the effect of postoperative interferon alpha (IFN alpha) treatment on recurrence and survival in patients with hepatitis B virus (HBV)-related HCC...
  55. ncbi request reprint A decade's studies on metastasis of hepatocellular carcinoma
    Zhao You Tang
    Liver Cancer Institute, Zhongshan Hospital, 136 Yi Xue Yuan Road, 200032, Shanghai, PR China
    J Cancer Res Clin Oncol 130:187-96. 2004
    ..The further elucidation of the mechanism underlying HCC metastasis will provide a more solid basis for the prediction and prevention of the metastatic recurrence of HCC...
  56. ncbi request reprint A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Cancer J 10:307-16. 2004
    ..Historically, radiotherapy for hepatocellular carcinoma has yielded poor long-term survival. Multimodality therapy has been initiated in an effort to improve survival statistics...
  57. ncbi request reprint Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma
    Hui Chuan Sun
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    J Hepatol 47:684-90. 2007
    ..To study the impact of hepatitis B e antigen on tumor recurrence and patients' survival after curative resection of hepatocellular carcinoma...
  58. ncbi request reprint Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases
    Jian Zhou
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P R China
    Hepatogastroenterology 53:275-80. 2006
    ..The risk factors may differ at different postoperative intervals. This study was undertaken to clarify the surgical outcome and time dependency of factors influencing survival in these patients...
  59. ncbi request reprint Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
    Qiang Gao
    Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, the Chinese Ministry of Education, Shanghai, People s Republic of China
    J Clin Oncol 25:2586-93. 2007
    ..To investigate the prognostic value of tumor-infiltrating lymphocytes (TILs), especially regulatory T cells (Tregs), in hepatocellular carcinoma (HCC) patients after resection...
  60. ncbi request reprint Radiation therapy for adrenal gland metastases from hepatocellular carcinoma
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Jpn J Clin Oncol 35:61-7. 2005
    ..External beam radiation therapy has seldom been applied for patients with adrenal gland metastases...
  61. doi request reprint Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC
    Yong Yi
    Key Laboratory for Carcinogenesis and Cancer Invasion, Liver Cancer Institute, Zhongshan Hospital, Fudan University, the Chinese Ministry of Education, Shanghai, People s Republic of China
    Ann Surg Oncol 20:267-76. 2013
    ..However, their roles in the progression of hepatocellular carcinoma (HCC) remain poorly described...
  62. ncbi request reprint Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Int J Radiat Oncol Biol Phys 63:1067-76. 2005
    ..To evaluate the role of radiotherapy (RT) for hepatocellular carcinoma (HCC) patients with abdominal lymph node (LN) metastasis at our institution in the past 7 years...
  63. doi request reprint Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone
    Ya Bo Gao
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China
    J Cancer Res Clin Oncol 139:669-79. 2013
    ..The biology underlying bone-specific metastasis (BM) of hepatocellular carcinoma (HCC) is poorly understood. The goal of the present study is to further elucidate the molecular and cellular mechanisms underlying HCC with BM...
  64. doi request reprint [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line]
    Wei Wei Li
    Liver Cancer Institute and Zhongshan Hospital, Fudan Unviersity, Shanghai 200032, China
    Zhonghua Gan Zang Bing Za Zhi 18:27-31. 2010
    ..To investigate the effects of ARNT2 on invasion and migration of HCCLM6 cells...
  65. doi request reprint Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
    Ai Wu Ke
    Experimental Research Center of Zhongshan Hospital, Fudan University, Shanghai, PR China
    Hepatology 49:491-503. 2009
    ..Conclusion: CD151 is positively associated with invasiveness of HCC, and CD151 or combination of CD151/c-Met is a novel marker in predicting the prognosis of HCC and a potential therapeutic target...
  66. doi request reprint Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma
    Zhen Bin Ding
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai 200032, China
    Cancer Res 68:9167-75. 2008
    ..The autophagy defects synergized with altered apoptotic activity might facilitate tumor malignant differentiation, which results in a more aggressive cancer cell phenotype and poor prognosis of HCC...
  67. doi request reprint [Effect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resection]
    Xiao hong Chen
    Liver Cancer Institute and Zhongshan Hospital of Fudan University, Shanghai 200032, China
    Zhonghua Gan Zang Bing Za Zhi 18:599-603. 2010
    ..To identify the effect of postoperative adjuvant transarterial chemoembolization (TACE) on late recurrence of hepatocellular carcinoma (HCC) patients after radical resection...
  68. ncbi request reprint [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma]
    Zuo Lin Xiang
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Zhong Liu Za Zhi 32:344-9. 2010
    ....
  69. ncbi request reprint [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria]
    Jia Fan
    Department of Liver Surgery and Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China
    Zhonghua Yi Xue Za Zhi 86:1227-31. 2006
    ..To evaluate the effects of different selection criteria on the prognosis of hepatocellular carcinoma (HCC) patients undergoing liver transplantation (LT) and to explore the new criteria adapted for Chinese National Situation...
  70. doi request reprint Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues
    Qiang Gao
    Key Laboratory for Carcinogenesis and Cancer Invasion, the Chinese Ministry of Education, Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, Shanghai, People s Republic of China
    J Cancer Res Clin Oncol 134:979-86. 2008
    ..To investigate the most suitable housekeeping genes for quantifying a change in mRNA expression levels due to hepatitis virus B related hepatocellular carcinoma (HCC)...
  71. ncbi request reprint [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma]
    Yang Xu
    Department of Hepato Surgery, Zhongshan Hospital, Liver Cancer Institute, Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 87:2101-4. 2007
    ..To identify the influence of tumor characteristics on the outcome of liver transplantation (LT) among patients with hepatocellular carcinoma (HCC)...
  72. doi request reprint Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma
    Bo Hui
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    Cancer 118:5560-71. 2012
    ..Proteasome inhibitors have been approved in clinical use against hematologic malignancies, but their application in solid tumors is uncertain. Moreover, the role of autophagy after proteasome inhibition is controversial...
  73. pmc IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
    Fang Ming Gu
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P R China
    Mol Cancer 10:150. 2011
    ..However, their relevance in cancer biology remains controversial. This study aimed to clarify the biological action of IL-17 on hepatocellular carcinoma (HCC)...
  74. doi request reprint Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma
    Qiang Gao
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School, Fudan University, Shanghai, People s Republic of China
    Ann Surg Oncol 19:455-66. 2012
    ..However, the relative roles of TIC density in predicting tumor extrahepatic metastasis remain to be elucidated...
  75. ncbi request reprint Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma
    Ji Gang Qiu
    Liver Cancer Institute and Department of Liver Surgery, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan, Shanghai 200032, China
    J Cancer Res Clin Oncol 134:299-305. 2008
    ..Serum low molecular weight protein biomarkers might be important in relation to portal vein tumor thrombi (PVTT) in hepatocellular carcinoma (HCC). This study aimed to screen and to detect these biomarkers...
  76. doi request reprint Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation
    Min Jie Ju
    Liver Cancer Institute, Zhongshan Hospital and Shanghai Medical School of Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, Chinese Ministry of Education, Shanghai, People s Republic of China
    J Gastroenterol 44:635-42. 2009
    ..The relationship between the prognosis of hepatitis B-associated hepatocellular carcinoma (HCC) and preoperative GGT/ALT is studied in hepatectomized Child-Pugh A patients...
  77. pmc Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice
    Chun Li Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China
    BMC Cancer 11:150. 2011
    ..Here, we explored the preclinical effects and molecular mechanisms of isomalto oligosaccharide sulfate (IMOS), another novel sulfated oligosaccharide, in HCC cell lines and a xenograft model...
  78. ncbi request reprint Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients
    Lun Xiu Qin
    Liver Cancer Institute, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China
    World J Gastroenterol 10:1397-401. 2004
    ..The prognosis of this type of patients is very dismal. The aim of this study was to share the experience in the diagnosis and treatment of HCC with BDT, to further improve the prognosis of these patients...
  79. doi request reprint Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection
    Guo Huan Yang
    Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People Republic of China
    Oncologist 13:1155-65. 2008
    ..Osteopontin (OPN) plays important roles in tumor progression and metastasis through binding to CD44 and integrin. The goal of this study was to elucidate the prognostic significance of OPN and CD44 in hepatocellular carcinoma patients...
  80. doi request reprint Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 136 Yi Xue Road, Shanghai 200032, China
    Cancer Sci 99:2510-7. 2008
    ....
  81. ncbi request reprint [Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma]
    Xiao hong Chen
    Department of Liver Medical Oncology, Liver Cancer Institute, Zhongshan Hospital of Fudan University, Shanghai 200032, China
    Zhonghua Yi Xue Za Zhi 90:826-9. 2010
    ..To explore the effect of postoperative adjuvant transarterial chemoembolization (TACE) upon early recurrence of hepatocellular carcinoma (HCC) patients after radical resection...
  82. doi request reprint The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis
    Yonglei Liu
    Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China
    Cell Signal 23:827-36. 2011
    ..In addition, CAPN6 promoted cancer cell proliferation and inhibited its apoptosis. The finding demonstrates that CAPN6 is regulated by the PI3K-Akt signaling pathway and provides evidence that it may be a therapeutic target of cancer...
  83. doi request reprint Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance
    Yun Fan Sun
    Key Laboratory of Carcinogenesis and Cancer Invasion Ministry of Education, Liver Cancer Institute, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, People s Republic of China
    J Cancer Res Clin Oncol 137:1151-73. 2011
    ....
  84. ncbi request reprint [Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells]
    Yong Sheng Xiao
    Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Zhong Liu Za Zhi 30:444-7. 2008
    ..To examine how the thymidine phosphorylase (TP) gene expression is upregulated by interferon-alpha (IFN-alpha) in human hepatocellular carcinoma SMMC-7721 cells...
  85. doi request reprint Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases
    Xin Da Zhou
    Liver Cancer Institute, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032 Shanghai, China
    J Cancer Res Clin Oncol 135:1067-72. 2009
    ..To clarify the clinicopathologic features of patients surviving > or =20 years after resection for hepatocellular carcinoma (HCC)...
  86. ncbi request reprint [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma]
    Jia Fan
    Institute of Liver Cancer, Department of Hepatic Surgery, Zhongshan Hospital of Fudan University, Shanghai 200032, China
    Zhonghua Wai Ke Za Zhi 43:433-5. 2005
    ..To evaluate the effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma (HCC)...
  87. ncbi request reprint [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]
    Zheng gang Ren
    Liver Cancer Intitute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Zhonghua Zhong Liu Za Zhi 26:116-8. 2004
    ..To evaluate the effect of postoperative adjuvant transcatheter arterial chemoembolization (TACE) on hepatocellular carcinoma (HCC) patients with residual tumor...
  88. ncbi request reprint [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases]
    Jian Min Xu
    Department of General Surgery, Zhongshan Hospital, China
    Zhonghua Zhong Liu Za Zhi 29:54-7. 2007
    ....
  89. ncbi request reprint Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis
    Wei Min Wang
    Institute of Biomedical Sciences, Fudan University, Shanghai, China
    Hepatobiliary Pancreat Dis Int 10:346-55. 2011
    ..The prognostic role of diabetes mellitus (DM) coexisting with hepatocellular carcinoma (HCC) remains controversial. To clarify its impact on survival in HCC patients after curative treatments, a meta-analysis was performed...
  90. ncbi request reprint Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy
    Hui Chuan Sun
    Live Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, People s Republic of China
    J Surg Oncol 96:37-45. 2007
    ..To study lymph node metastasis (LNM) and prognosis in patients with operable hepatocellular carcinoma (HCC) as well as the value of routine complete lymphadenectomy. Few studies have been reported on LNM in patients with operable HCC...
  91. ncbi request reprint Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE
    Fu hua Yan
    Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China
    World J Gastroenterol 8:658-62. 2002
    ..To evaluate the role and limitation of fast multiplanar spoiled gradient-recalled (FMPSPGR) MR dynamic contrast scanning in the follow-up of patients with HCC treated by transarterial chemoembolization (TACE)...
  92. ncbi request reprint [Comparison of the results and therapies for hepatocellular carcinoma with tumor thrombosis in portal vein]
    Jia Fan
    Institute of Liver Cancer, Zhongshan Hospital of Fudan University, Shanghai 200032, China
    Zhonghua Wai Ke Za Zhi 41:801-4. 2003
    ..To compare the clinical effects of different therapies on hepatocellular carcinoma (HCC) with portal vein tumor thrombi (PVTT), and to study the factors that affected the prognosis...
  93. ncbi request reprint Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT
    Fuhua Yan
    Department of Radiology, Zhongshan Hospital, Fudan University former Zhongshan Hospital, Shanghai Medical University, No 180 Fenglin Road, Shanghai 200032, People s Republic of China
    Eur J Radiol 41:12-8. 2002
    ..As for atypical cases, the diagnosis remained difficult and should be differentiated from other hypervascular lesions by means of other imaging modalities or needle puncture biopsy...
  94. ncbi request reprint Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    Hepatogastroenterology 51:201-7. 2004
    ..In this paper, we report 29 hepatocellular carcinoma patients with abdominal lymph node metastasis who received EBRT over a period of 5 years...
  95. doi request reprint Hepatectomy for liver metastasis of colorectal cancer
    Jianmin Xu
    Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People s Republic of China
    Int J Colorectal Dis 24:419-25. 2009
    ..The objective of this study was to investigate whether hepatic resection (HR) can increase the survival of liver metastasis of colorectal cancer (CRC)...
  96. ncbi request reprint [Segmentectomy for hepatoma originated from segment IX]
    Zhi Quan Wu
    Liver Cancer Institute, Zhongshan Hospital of Fudan University, Shanghai 200032, China
    Zhonghua Wai Ke Za Zhi 42:1033-5. 2004
    ..To report the procedure of segmentectomy for hepatoma located in segment IX...
  97. ncbi request reprint A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
    Zhao Chong Zeng
    Radiation Oncology, Fudan University, Zhongshan Hospital, Shanghai 200032, China
    Int J Radiat Oncol Biol Phys 61:432-43. 2005
    ..To evaluate the potential role of external beam radiation therapy (EBRT) in the treatment of patients with hepatocellular carcinoma (HCC) who have portal vein (PV) and/or inferior vena cava (IVC) tumor thrombi...
  98. pmc Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
    Ying Hong Shi
    Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    Hepatology 48:497-507. 2008
    ..XIAP expression was also highly correlated with advanced cases that exceeded the Milan criteria and could be a prognostic factor for disease-free survival in these patients as well...
  99. ncbi request reprint Surgery for large primary liver cancer more than 10 cm in diameter
    Xin Da Zhou
    The Liver Cancer Institute, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032, Shanghai, China
    J Cancer Res Clin Oncol 129:543-8. 2003
    ..Large primary liver cancer (PLC) more than 10 cm in diameter is not infrequently encountered in clinical practice. This study evaluated the clinicopathological features and long-term results after surgery for large PLC...
  100. ncbi request reprint [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
    Xiaofeng Wu
    Liver Cancer Institute, Fudan University, Shanghai 200032, China
    Zhonghua Gan Zang Bing Za Zhi 10:189-91. 2002
    ..To assess the level of alpha-fetoprotein (AFP) messenger RNA (mRNA) in peripheral blood of nude mice, and to study its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma (HCC)...
  101. ncbi request reprint Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma
    Zhao Chong Zeng
    Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai, 200032, P R China
    Eur J Nucl Med Mol Imaging 29:1657-68. 2002
    ..However, RIT is much less toxic than EBRT, the side-effects of which include radiation injury to the liver and disturbance of T lymphocyte subsets...